We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cells of Pulmonary Fibrosis Derive from Bone Marrow Stem Cells

By Biotechdaily staff writers
Posted on 02 Feb 2004
Researchers have found that cells that underlie pulmonary fibrosis derive from bone marrow stem cells rather than from parnechymal lung fibroblasts.

Pulmonary fibrosis is a condition in which excessive scar tissue is deposited in the lungs, making them stiff and small and interfering with their function. Investigators at the University of Michigan (Ann Arbor, USA) induced pulmonary fibrosis in a line of mice that had been genetically engineered to produce bone marrow stem cells that expressed a green fluorescent protein. They reported in the January 15, 2004, issue of the Journal of Clinical Investigation that the majority of the collagen-producing cells involved in active fibrotic lesions expressed the green fluorescent protein, indicating that they had derived from bone marrow stem cells.

These findings confirm that lung fibroblasts in pulmonary fibrosis are derived from bone marrow stem cells.




Related Links:
University of Michigan

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Urine Analyzer
respons® UDS100

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
02 Feb 2004  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
02 Feb 2004  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
02 Feb 2004  |   BioResearch